Team:USC/Notebook/Week13
From 2011.igem.org
(Difference between revisions)
Line 320: | Line 320: | ||
<br /> | <br /> | ||
HT115 CRISPR::GFP #7 | HT115 CRISPR::GFP #7 | ||
+ | <br /> | ||
+ | 2. Dilution: plate on Amp #4 and #5 +/- IPTG, #4 and #5 have different OD values. Dilute 1000* and 5000* to both of them | ||
+ | <br /> | ||
+ | 3. Digest pSB1C3 and tetO/R vector | ||
+ | <br /> | ||
+ | 4. Transform casO#1, #2, #1, #2 on CM plates | ||
+ | <br /> | ||
+ | |||
+ | |||
+ | <span style="font-family:Verdana; font-weight:700;"> 09/22/2011 </span> | ||
+ | <br /> | ||
+ | 1. Inoculation casO and cas3 into 24 tubes | ||
+ | Notes: casO#1 goes to 1-6, casO#2 goes to 7-12; cas3#1 goes to another 1-6, cas3#2 goes to another 7-12 | ||
+ | <br /> | ||
+ | |||
+ | <span style="font-family:Verdana; font-weight:700;"> 09/23/2011 </span> | ||
+ | <br /> | ||
+ | 1. Mini-prep all the casO and cas3 samples | ||
+ | <br /> | ||
+ | 2. Digest them by different enzymes | ||
+ | <br /> | ||
+ | 3. Ligate them with pSB1C3 vectors | ||
+ | <br /> | ||
+ | |||
+ | <span style="font-family:Verdana; font-weight:700;"> 09/24/2011 </span> | ||
+ | <br /> | ||
+ | 1. Transform all the ligated products into competent cells | ||
+ | <br /> | ||
+ | 2. Inoculate them in LB media | ||
+ | <br /> | ||
+ | |||
+ | <span style="font-family:Verdana; font-weight:700;"> 09/25/2011 </span> | ||
+ | <br /> | ||
+ | 1. Mini-prep the biobrick products | ||
+ | <br /> | ||
+ | 2. Verify them by PCR | ||
+ | <br /> | ||
+ | |||
+ | <span style="font-family:Verdana; font-weight:700;"> 09/25/2011 </span> | ||
+ | <br /> | ||
+ | 1. Transform | ||
+ | the casO plasmid into BL21; cas3; tetO::GFP; CRISPR-GFP | ||
+ | <br /> | ||
+ | 2. Inoculate the above plasmids | ||
+ | <br /> | ||
+ | |||
+ | <span style="font-family:Verdana; font-weight:700;"> 09/27/2011 </span> | ||
+ | <br /> | ||
+ | 1. Do growth test for the following BL21 cells: | ||
+ | <br /> | ||
+ | BL21 tetO::GFP-IPTG | ||
+ | <br /> | ||
+ | BL21 tetO::GFP+IPTG | ||
+ | <br /> | ||
+ | BL21 tetO::GFP+IPTG(2 hours later) | ||
+ | <br /> | ||
+ | BL21 tetO::GFP, CRISPR::GFP-IPTG | ||
+ | <br /> | ||
+ | BL21 tetO::GFP, CRISPR::GFP+IPTG | ||
+ | <br /> | ||
+ | BL21 tetO::GFP, CRISPR::GFP+IPTG(2 hours later) | ||
+ | <br /> | ||
+ | BL21 tetO::GFP, CRISPR::GFP+cas3-IPTG | ||
+ | <br /> | ||
+ | BL21 tetO::GFP, CRISPR::GFP+cas3+IPTG | ||
+ | <br /> | ||
+ | BL21 tetO::GFP, CRISPR::GFP+cas3+IPTG(2 hours later) | ||
+ | <br /> | ||
+ | BL21 tetO::GFP, CRISPR::GFP+cas3+casA-E-IPTG | ||
+ | <br /> | ||
+ | BL21 tetO::GFP, CRISPR::GFP+cas3+casA-E+IPTG | ||
+ | <br /> | ||
+ | BL21 tetO::GFP, CRISPR::GFP+cas3+casA-E+IPTG(2 hours later) | ||
+ | <br /> | ||
+ | BL21 tetO::GFP, CRISPR::GFP+cas3+casA-2-IPTG | ||
+ | <br /> | ||
+ | BL21 tetO::GFP, CRISPR::GFP+cas3+casA-2+IPTG | ||
+ | <br /> | ||
+ | BL21 tetO::GFP, CRISPR::GFP+cas3+casA-2+IPTG(2 hours later) | ||
<br /> | <br /> | ||
</table> | </table> |